David A. Ehrmann

11.5k total citations · 4 hit papers
60 papers, 7.2k citations indexed

About

David A. Ehrmann is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David A. Ehrmann has authored 60 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Reproductive Medicine, 22 papers in Public Health, Environmental and Occupational Health and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David A. Ehrmann's work include Ovarian function and disorders (36 papers), Reproductive Biology and Fertility (21 papers) and Sleep and related disorders (12 papers). David A. Ehrmann is often cited by papers focused on Ovarian function and disorders (36 papers), Reproductive Biology and Fertility (21 papers) and Sleep and related disorders (12 papers). David A. Ehrmann collaborates with scholars based in United States, France and Iceland. David A. Ehrmann's co-authors include Robert L. Rosenfield, Melissa K. Cavaghan, Eve Van Cauter, Esra Tasali, Jacqueline Imperial, Randall B. Barnes, Rachel Leproult, Ricardo Azziz, Kenneth S. Polonsky and Richard S. Legro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

David A. Ehrmann

58 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited

2016 1.0k citations Robert L. Rosenfield, David A. Ehrmann profile →
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1999 971 citations David A. Ehrmann, Robert L. Rosenfield et al. profile →
Slow-wave sleep and the risk of type 2 diabetes in humans

2008 688 citations Esra Tasali, Rachel Leproult et al. profile →
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

2006 516 citations David A. Ehrmann, David R. Liljenquist et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Ehrmann United States	34	4.4k	2.9k	1.8k	1.1k	1.0k	60	7.2k
Jacqueline Imperial United States	20	1.5k 0.3×	1.5k 0.5×	663 0.4×	508 0.5×	546 0.5×	21	3.4k
Daniela Jakubowicz Venezuela	38	3.7k 0.8×	3.2k 1.1×	1.7k 1.0×	607 0.5×	1.3k 1.3×	65	6.2k
Valentina Vicennati Italy	40	1.5k 0.4×	1.0k 0.4×	2.6k 1.5×	448 0.4×	1.2k 1.1×	122	5.7k
Bülent Okan Yıldız Türkiye	42	8.9k 2.0×	5.6k 1.9×	2.2k 1.2×	1.2k 1.0×	1.1k 1.1×	151	12.1k
Alessandra Gambineri Italy	43	4.6k 1.0×	2.7k 0.9×	2.3k 1.3×	710 0.6×	910 0.9×	143	7.2k
Gian Benedetto Melis Italy	42	3.1k 0.7×	1.0k 0.3×	1.1k 0.6×	368 0.3×	394 0.4×	230	6.4k
Corrine K. Welt United States	44	4.4k 1.0×	3.4k 1.2×	1.3k 0.8×	319 0.3×	503 0.5×	105	7.4k
Peter Y. Liu United States	39	1.1k 0.2×	663 0.2×	2.4k 1.3×	304 0.3×	2.0k 1.9×	111	5.8k
Risto Erkkola Finland	35	587 0.1×	1.0k 0.4×	943 0.5×	475 0.4×	225 0.2×	186	4.1k
Alexia Peña Australia	23	2.2k 0.5×	1.7k 0.6×	1.1k 0.6×	515 0.5×	363 0.4×	73	4.3k

Countries citing papers authored by David A. Ehrmann

Since Specialization

Citations

This map shows the geographic impact of David A. Ehrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Ehrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Ehrmann more than expected).

Fields of papers citing papers by David A. Ehrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Ehrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Ehrmann. The network helps show where David A. Ehrmann may publish in the future.

Co-authorship network of co-authors of David A. Ehrmann

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Ehrmann. A scholar is included among the top collaborators of David A. Ehrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Ehrmann. David A. Ehrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doycheva, Iliana & David A. Ehrmann. (2022). Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. Fertility and Sterility. 117(5). 897–911. 16 indexed citations

Morselli, Lisa L., Karla A. Temple, Rachel Leproult, et al.. (2018). Determinants of Slow-Wave Activity in Overweight and Obese Adults: Roles of Sex, Obstructive Sleep Apnea and Testosterone Levels. Frontiers in Endocrinology. 9. 377–377. 13 indexed citations

Temple, Karla A., Rachel Leproult, Lisa L. Morselli, et al.. (2018). Sex Differences in the Impact of Obstructive Sleep Apnea on Glucose Metabolism. Frontiers in Endocrinology. 9. 376–376. 15 indexed citations

Mokhlesi, Babak, Karla A. Temple, Ashley N. Hogan, et al.. (2018). Self-Reported Sleep and Circadian Measures Are Not Associated with Glycemia in Adults with Prediabetes or Early Untreated Type 2 Diabetes (T2D). Diabetes. 67(Supplement_1).

Rosenfield, Robert L., David A. Ehrmann, & Elizabeth Littlejohn. (2015). Adolescent Polycystic Ovary Syndrome Due to Functional Ovarian Hyperandrogenism Persists Into Adulthood. The Journal of Clinical Endocrinology & Metabolism. 100(4). 1537–1543. 23 indexed citations

Cauter, Eve Van & David A. Ehrmann. (2010). Preface. Best Practice & Research Clinical Endocrinology & Metabolism. 24(5). vii–viii. 3 indexed citations

Ehrmann, David A., et al.. (2010). Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Practice & Research Clinical Endocrinology & Metabolism. 24(5). 717–730. 29 indexed citations

Kawai, Toshihide, Maggie Ng, M. Geoffrey Hayes, et al.. (2009). Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome. Diabetes Research and Clinical Practice. 86(3). 186–192. 11 indexed citations

Ehrmann, David A., et al.. (2008). Cardiometabolic features of polycystic ovary syndrome. Nature Clinical Practice Endocrinology & Metabolism. 4(4). 215–222. 65 indexed citations

10.

Ehrmann, David A., David R. Liljenquist, Kristen Kasza, et al.. (2006). Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 91(1). 48–53. 516 indexed citations breakdown →

11.

Qin, Kenan, David A. Ehrmann, Nancy J. Cox, Samuel Refetoff, & Robert L. Rosenfield. (2006). Identification of a Functional Polymorphism of the Human Type 5 17β-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 91(1). 270–276. 57 indexed citations

12.

Tasali, Esra, Eve Van Cauter, & David A. Ehrmann. (2006). Relationships between Sleep Disordered Breathing and Glucose Metabolism in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 91(1). 36–42. 82 indexed citations

13.

Ehrmann, David A., Kristen Kasza, Ricardo Azziz, Richard S. Legro, & Mahmoud N. Ghazzi. (2005). Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 90(1). 66–71. 148 indexed citations

14.

Alcoser, Sergio Y., Manami Hara, Graeme I. Bell, & David A. Ehrmann. (2004). Association of the (AU)AT-Rich Element Polymorphism inPPP1R3with Hormonal and Metabolic Features of Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 89(6). 2973–2976. 4 indexed citations

15.

Ehrmann, David A.. (2004). Genetic contributions to glucose intolerance in polycystic ovary syndrome. Reproductive BioMedicine Online. 9(1). 28–34. 5 indexed citations

16.

Azziz, Ricardo, et al.. (2003). Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. Fertility and Sterility. 79(4). 932–937. 66 indexed citations

17.

Ehrmann, David A. & Daniel F. Rychlik. (2003). Pharmacologic Treatment of Polycystic Ovary Syndrome. Seminars in Reproductive Medicine. 21(3). 277–284. 13 indexed citations

18.

Hara, Manami, et al.. (2002). Insulin Resistance Is Attenuated in Women with Polycystic Ovary Syndrome with the Pro¹²Ala Polymorphism in the PPARγ Gene. The Journal of Clinical Endocrinology & Metabolism. 87(2). 772–775. 78 indexed citations

19.

Ehrmann, David A.. (2002). Insulin resistance and polycystic ovary syndrome. Current Diabetes Reports. 2(1). 71–76. 17 indexed citations

20.

Ehrmann, David A., Robert L. Rosenfield, Leona Cuttler, et al.. (1989). A New Test of Combined Pituitary-Testicular Function Using the Gonadotropin-Releasing Hormone Agonist Nafarelin in the Differentiation of Gonadotropin Deficiency from Delayed Puberty: Pilot Studies*. The Journal of Clinical Endocrinology & Metabolism. 69(5). 963–967. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact